Special Issue "Progress in Nanoformulations for Nanomedicine"
Deadline for manuscript submissions: closed (15 June 2023) | Viewed by 250
Interests: nanomaterials; nanomedicine; photocatalysis; bioremediation; sustainability; green chemistry; nanotoxicity; environmental engineering; pharmaceutics; nanotheranostics; nanosensing
Special Issues, Collections and Topics in MDPI journals
Special Issue in Sustainability: Frontiers in Metallic Nanoparticles
Special Issue in International Journal of Molecular Sciences: Advanced Functional and Tunable Cancer Nanotheranostics
Special Issue in Crystals: Nanocrystal Technology & BCS Class II and Class IV Drug Delivery: Experimental Advances and Clinical Applications
Special Issue in Crystals: Advanced Nanomaterials and Their Applications
Interests: vecteurs; nanoparticules; microparticules; liposomes; cyclodextrines; dispersion solide; dispositifs transdermiques; biodisponibilité; absorption; formulation
The discovery and characterization of new therapeutic targets and strategies are a permanent process for effective translational medicine and health promotion.
This Special Issue (SI) aims to report innovative and smart nanoformulations based on biochemical compounds (cyclic peptides, peptide hormones, lipopeptides, peptide conjugates, nucleic-acid-based drugs, phytochemicals), as well as phytoextracts, antibody–drug conjugates, and chemical-drug-based nanoformulations. Their physical–chemical, molecular, and/or pharmacological characterizations must be detailed. The underlying molecular mechanisms including key regulated signaling pathways and cell/tissue–drug interactions will be further appreciated.
A preference will be given to smart, controlled, and site-targeted nanotheranostics. Reports of effective treatments of diseases by nanobiotechnology-driven products (e.g., nanoformulations) will be much appreciated.
This SI is open for the publication of studies conducted at the basic science level and preclinical studies. We cordially invite research scholars (e.g., students, pharmacists, industrials, biologists, nanotechnologists, bioengineers, physicians) from all around the world to consider submitting their work, should it be original research, review articles, or comprehensive preclinical studies that address the challenges in bringing biological agents or novel targeted theranostic strategies through drug compound identification, development, and potential translation from bench to bedside.
Prof. Dr. Farid Menaa
Dr. Mohamed Skiba
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- drug development
- drug processing
- controlled and site-directed drug release
- drug toxicity
- translational medicine
- therapeutic innovation
- drug formulation
- translational medicine